Deals
The Eurazeo group raised EUR2.8 billion from its investor partners across 2020, an increase of 18 per cent compared with 2019.
Amid a volatile context caused by the Covid-19 crisis, this strong performance provides further vindication of Eurazeo’s strategy of diversification. The Group remains a leading investor in private markets and one of the few in Europe to offer clients investment solutions in three high-return asset classes (Private Equity, private debt and real assets), covering the whole business development cycle (Venture, Growth, SME, mid-to-large cap), and with expertise in all promising business sectors. The trust placed in Eurazeo by major
Blue Point Capital Partners (Blue Point) has made its eighth Blue Point IV platform investment with the acquisition of Cleveland-based Transtar Holding Company (Transtar).
Transtar is a global leader in the value-added distribution of original equipment and aftermarket automotive products for the transmission and driveline repair market. The local partnership with Blue Point will accelerate the Company’s growth through continued refinement of its industry-leading e-commerce technology, enhancement of supply chain efficiencies and execution of strategic add-on acquisitions.
Transtar has distributed thousands of high-quality branded and propriety parts to transmission repair shops and other automotive channels around the globe since 1975.
Global law firm White & Case has advised Memsource, an AI-powered translation management system headquartered in the Czech Republic, and its majority shareholder The Carlyle Group, on the acquisition of a majority stake in Phrase, a German software localisation platform, from its existing shareholders.
“Our international team helped to successfully navigate this important strategic acquisition, which is the first since Carlyle’s investment in Memsource last year,” says White & Case partner Ken Barry, who led the Firm’s deal team. “The strong combination of Memsource and Phrase together with Carlyle’s investment in this accelerating sector highlights White & Case’s robust expertise
Swander Pace Capital (SPC) has completed the sale of Clarion Brands, a consumer products company specialising in over-the-counter (OTC) healthcare solutions and dietary supplements, to Bridges Consumer Healthcare LLC, a consumer healthcare company partnering with Charlesbank Capital Partners.
Clarion markets a portfolio of leading niche OTC and dietary supplements brands that are sold to food, drug, mass, and online retailers throughout the United States and Canada.
Swander Pace Capital partnered with the former management team of Insight Pharmaceuticals following its sale to Prestige Brands Holdings in 2014, and created the Clarion consumer healthcare platform. Under the ownership of SPC,
Caring Brands International (CBI), a portfolio company of Levine Leichtman Capital Partners (LLCP), has completed the acquisition of its Interim HealthCare home health and hospice franchises in San Diego.
The addition of the San Diego Franchise expands CBI’s branch footprint and marks the first acquisition within the Interim HealthCare network domestically.
Founded in 1966, CBI is the largest franchisor of home healthcare services globally and produces approximately USD1.1 billion of annual systemwide sales across over 550 global locations. CBI offers franchises under three brands: Interim HealthCare (United States), Bluebird Care (United Kingdom and Republic of Ireland) and Just Better Care
A new report by technology-focused investment bank ICON Corporate Finance, has revealed that despite Covid causing a 50 per cent year-on-year collapse in Tech M&A activity in the second quarter, a remarkable bounce-back led to a spate of M&A activity in businesses focussed on Digital Transformation, resulting in a near record final quarter, boding well for 2021.
The report, which analyses some of the largest and most interesting FinTech deals in 2020, and which looks at trends in the tech sector, saw M&A activity rally, up 6 per cent in Q4 compared 2019, which had itself been a record year
Enhanced Healthcare Partners (EHP), a healthcare-focused private equity firm, has exited its platform investment in SCA Pharmaceuticals (SCA Pharma) through the sale of the business to The Vistria Group and Excellere Capital Management.
An FDA 503(B) outsourcing facility, SCA Pharma delivers sterile admixtures and pre-filled syringes to hospitals and health systems nationwide. SCA alleviates common problems health care facilities face such as wasted product, drug shortages, time-consuming processes, compliance issues, staffing costs, and patient safety concerns. Over the past five years, the Company has deeply invested in facility expansion, infrastructure, automation and quality to support the Company’s growth.
SCA
CDC Group, a UK-based impact investor and development finance institution (DFI), has announced a commitment to invest over USD1 billion again in African businesses in 2021.
The commitment will enable CDC to invest in many more promising African entrepreneurs and SMEs, and continue to drive inclusive growth and job creation across the continent, where over half of the institution’s portfolio is now invested. The funds will be invested in financial institutions, infrastructure and climate, services, manufacturing, agriculture, real estate and technology.
In 2020, CDC committed over USD1 billion into Africa with a focus was the economic recovery from
Funds managed by Clayton, Dubilier & Rice (CD&R) are partnering with current owners and management of S&S Activewear to acquire the North American distributor of imprintable apparel and accessories. Terms of the transaction have not been disclosed.
With approximately four million square feet of warehouse space and more than 2,000 employees, S&S specialises in distributing blank sportswear, corporate apparel, and accessories, including t-shirts, fleece & sweatshirts, headwear, athletics and outerwear from over 100 leading brands such as adidas, Champion, Columbia, Bella+Canvas, Next Level Apparel and Gildan. The company stocks more than 80,000 products and serves a broad range of customers,
Big Issue Invest, the social investment arm of The Big Issue, and the University of Oxford’s Government Outcomes Lab (GO Lab) within the Blavatnik School of Government, have release the ‘Exploring Social Investment – An Indigo Technical & Learning Report’ detailing their collaboration towards data sharing in the social outcomes contract sector.
The report showcases how Big Issue Invest (BII) and GO Lab worked together to publish the contract, finance and impact data for the investments made within Big Issue Invests’ Outcomes Investment Fund (OIF).
The report launch coincides with GO Lab’s launch of the ‘International Network for Data on
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
